VHH Single Domain Anti-Rabbit IgG Fc (HRP)
- Recombinant
- What is this?
5
(2 Reviews)
|
(112 Publications)
Recombinant secondary antibody suitable for IHC-P, WB, ELISA. Ideal for western blot. Cited in 112 publications.
View Alternative Names
Ig gamma 1 chain C region, Ig gamma 3 chain C region, Ig gamma 4 chain C region, Ig gamma chain C region, Ig gamma-2 chain C region, Ig kappa-b4 chain C region, Ig kappa-b5 chain C region, Ig kappa-b9 chain C region, Ig lambda chain C region, Immunoglobin heavy constant gamma 1, Immunoglobulin G, K-BAS
- WB
AbReview45923****
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
Blocking Solution and Diluent 5% milk in TBS
All lanes:
Western blot - Anti-KAT3B / p300 antibody (<a href='/en-us/products/primary-antibodies/kat3b-p300-antibody-ab10485'>ab10485</a>) at 1/5000 dilution
Lane 1:
Human MCF-7 Cell Lysate at 50000 Cells
Lane 2:
MDA-MB-231 Cell Lysate at 50000 Cells
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866)
Predicted band size: 264 kDa
true
Exposure time: 3min
This image is courtesy of an anonymous Abreview
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 1% Milk before being incubated with ab70358 overnight at 4°C. Antibody binding was detected using an anti-rabbit VHH single domain antibody conjugated to HRP, and visualised using ECL development solution ab133406.
Abcam recommends using milk as the blocking agent. Abcam welcomes customer feedback and would appreciate any comments regarding this product and the data presented above.
All lanes:
Western blot - Anti-PCK1/PEPC antibody (<a href='/en-us/products/primary-antibodies/pck1-pepc-antibody-ab70358'>ab70358</a>) at 1 µg
Lane 1:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
Liver (Rat) Tissue Lysate at 10 µg
Lane 3:
Liver (Mouse) Tissue Lysate at 10 µg
Lane 4:
Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution
Predicted band size: 69 kDa
Observed band size: 32 kDa,45 kDa,69 kDa
true
Exposure time: 20s
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab25949 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866), and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-RBPJK antibody (<a href='/en-us/products/primary-antibodies/rbpjk-antibody-ab25949'>ab25949</a>) at 1 µg/mL
All lanes:
Human pancreas tissue lysate - total protein (<a href='/en-us/products/unavailable/human-pancreas-tissue-lysate-total-protein-ab29816'>ab29816</a>) at 20 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution
Predicted band size: 56 kDa
Observed band size: 56 kDa,98 kDa
true
Exposure time: 16min
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.
The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to Ki67 (ab15580, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.025μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.
The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
Top left : IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.
The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to Ki67 (ab15580, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.1μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.
Top right : this image shares the same experimental design parameters, except the secondary antibody was ab97051, goat anti-rabbit IgG H&L (HRP) (0.1μg/ml). This demonstrates the improved definition of staining given by VHH Single Domain Antibodies over conventional secondaries.
Bottom right : this image shares the same experimental design parameters but is a negative control (no primary antibody) for ab97051, demonstrating specificity of the goat anti-rabbit secondary antibody.
Bottom left : this image shares the same experimental design parameters but is a negative control (no primary antibody) for ab191866, demonstrating the specificity of the VHH-Single Domain Antibody.
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.
The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to beta tubulin (ab6046, 0.5μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.125μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.
The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human colon tissue section.
The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit polyclonal antibody to VDAC1 (ab15895, 1/1000 dilution) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 0.125μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.
The negative control (secondary antibody only, no primary) insert shows no staining, demonstrating secondary antibody specificity.
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
IHC image of VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) staining in formalin fixed paraffin embedded normal human cerebellum tissue section.
The section was dewaxed and then pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6) in a Dako Pascal pressure cooker using the standard factory-set regime. Non-specific protein-protein interactions were then blocked using in TBS containing 0.025% (v/v) Triton X-100, 0.3M (w/v) glycine and 3% (w/v) BSA for 1h at room temperature. The section was then incubated with rabbit monoclonal antibody [EPR12763] to NeuN (ab177487, 0.1μg/ml) in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA overnight at +4°C. Endogenous peroxidases were quenched using 1.6% (v/v) hydrogen peroxide in TBS containing 0.025% (v/v) Triton X-100 for 30 minutes at room temperature, with agitation. The secondary antibody, VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866, 1.0μg/ml) was then applied for 1 hour at room temperature in TBS containing 0.025% (v/v) Triton X-100 and 3% (w/v) BSA before being developed for 10 minutes at room temperature using Steady DAB/Plus (ab103723). The section was then counterstained with hematoxylin and mounted with DPX.
The negative control (secondary antibody only, no primary) inset shows no staining, demonstrating secondary antibody specificity.
For other IHC staining systems (automated and non-automated), customers should optimize variable parameters such as antigen retrieval conditions, antibody concentrations and incubation times.
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab5823 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-Histone H4 (symmetric di methyl R3) antibody (<a href='/en-us/products/primary-antibodies/histone-h4-symmetric-di-methyl-r3-antibody-ab5823'>ab5823</a>) at 1 µg
All lanes:
Calf Thymus Histone Preparation Nuclear Lysate at 0.5 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution
Predicted band size: 11 kDa
Observed band size: 14 kDa
true
Exposure time: 3min
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab45145 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406
Lanes 1 - 2:
Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/en-us/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/en-us/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/5000 dilution
Lanes 5 - 6:
Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/en-us/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/10000 dilution
Lanes 7 - 8:
Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/en-us/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/50000 dilution
Lanes 9 - 10:
Western blot - Anti-Aurora B antibody [EP1009Y] (<a href='/en-us/products/primary-antibodies/aurora-b-antibody-ep1009y-ab45145'>ab45145</a>) at 1/75000 dilution
Lanes 1, 3, 5, 7 and 9:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lanes 2, 4, 6, 8 and 10:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate Nocodozole Stimulated at 10 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/10000 dilution
Predicted band size: 39 kDa
Observed band size: 39 kDa
true
Exposure time: 8min
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab24193 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866), and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-n-Myc/MYCN antibody (<a href='/en-us/products/primary-antibodies/n-myc-mycn-antibody-ab24193'>ab24193</a>) at 1 µg/mL
Lane 1:
Heart (Human) Whole Cell Lysate - fetal normal tissue at 10 µg
Lane 2:
Heart (Mouse) Tissue Lysate at 10 µg
Lane 3:
Skeletal Muscle (Mouse) Tissue Lysate at 10 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution
Predicted band size: 50 kDa
Observed band size: 190 kDa,49 kDa
true
Exposure time: 30s
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
All lanes:
Western blot - Anti-GAPDH antibody - Loading Control (<a href='/en-us/products/primary-antibodies/gapdh-antibody-loading-control-ab37168'>ab37168</a>) at 1 µg/mL
Lanes 1 and 3:
HeLa Whole Cell Lysate at 10 µg
Lanes 2 and 4:
Jurkat Whole Cell Lysate at 10 µg
Secondary
Lanes 1 - 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.02 µg/mL
Lanes 3 - 4:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 0.02 µg/mL
Predicted band size: 11 kDa,54 kDa
true
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
All lanes:
Western blot - Anti-NRG1 type III antibody (<a href='/en-us/products/primary-antibodies/nrg1-type-iii-antibody-ab23248'>ab23248</a>) at 1 µg/mL
Lanes 1 and 3:
Mouse Brain Tissue Lysate at 10 µg
Lanes 2 and 4:
Rat Brain Tissue Lysate at 10 µg
Secondary
Lanes 1 - 2:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 0.05 µg/mL
Lanes 3 - 4:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 0.05 µg/mL
Predicted band size: 11 kDa
true
- WB
Lab
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (AB191866)
This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab16044 overnight at 4°C. Antibody binding was detected using VHH Single Domain Anti-Rabbit IgG Fc (HRP), and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-CD3 antibody (<a href='/en-us/products/primary-antibodies/cd3-antibody-ab16044'>ab16044</a>) at 1 µg/mL
Lane 1:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 2:
Thymus (Mouse) Tissue Lysate at 20 µg
Lane 3:
Thymus (Rat) Tissue Lysate at 20 µg
Secondary
All lanes:
Western blot - VHH Single Domain Anti-Rabbit IgG Fc (HRP) (ab191866) at 1/50000 dilution
Predicted band size: 19 kDa
Observed band size: 18 kDa,23 kDa,48 kDa,62 kDa
true
Exposure time: 8min
Related conjugates and formulations (1)
-
VHH Single Domain Anti-Rabbit IgG Fc
Reactivity data
You may be interested in:
Why is this recommended?
We recommend this product because it’s often used in the same experiment or related research.
We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (112)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 24: PubMed38139144
2023
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:18928 PubMed37919373
2023
Applications
Unspecified application
Species
Unspecified reactive species
Porcine health management 9:18 PubMed37069650
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC research notes 16:39 PubMed36941637
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed36980752
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e14171 PubMed36938470
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of assisted reproduction and genetics 40:343-359 PubMed36593322
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of reproduction & infertility 23:148-159 PubMed36415496
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 24:745 PubMed36561980
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36361998
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com